BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10637091)

  • 1. Shifting the balance: direct stenting a novel approach to improve the cost effectiveness of intra-coronary stenting.
    Cotton JM; Kearney MT; Wainwright RJ
    Eur Heart J; 2000 Jan; 21(2):170. PubMed ID: 10637091
    [No Abstract]   [Full Text] [Related]  

  • 2. Economics and outcomes of coronary stenting: are stents right for everybody?
    Weintraub WS
    J Invasive Cardiol; 2000 Apr; 12(4):200-2. PubMed ID: 10785673
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical economic considerations of coronary stenting.
    Szucs TD
    Schweiz Med Wochenschr; 1999 Nov; 129(45):1701-11. PubMed ID: 10595380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary stenting: costly or cost-effective?
    Cohen DJ; Baim DS
    J Invasive Cardiol; 1995; 7 Suppl A():36A-42A. PubMed ID: 10155115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coronary angioplasty: always a stent in arteries larger than 2.5 mm? The arguments con].
    Goicolea Ruigómez FJ; Macaya Miguel C
    Rev Esp Cardiol; 1999 Feb; 52(2):85-94. PubMed ID: 10073089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan.
    Ikeda S; Bosch J; Banz K; Schneller P
    J Invasive Cardiol; 2000 Apr; 12(4):194-9. PubMed ID: 10785672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dollars and sense of drug-eluting stents.
    Brophy JM
    CMAJ; 2005 Feb; 172(3):361-2. PubMed ID: 15684119
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.
    Reynolds MR; Neil N; Ho KK; Berezin R; Cosgrove RS; Lager RA; Sirois C; Johnson RG; Cohen DJ
    Am Heart J; 2003 Feb; 145(2):334-42. PubMed ID: 12595853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common sense, dollars and cents, and drug-eluting stents.
    Vaitkus PT
    J Am Coll Cardiol; 2006 Jul; 48(2):268-9. PubMed ID: 16843173
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coronary stents. Where are we? Where are we going?].
    Gaxiola E; Vlietstra RE; Pepine CJ
    Arch Inst Cardiol Mex; 1998; 68(4):337-45. PubMed ID: 9810372
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct coronary stenting compared with stenting after predilatation is feasible, safe, and more cost-effective in selected patients: evidence to date indicating similar late outcomes.
    Ijsselmuiden AJ; Tangelder GJ; Cotton JM; Vaijifdar B; Kiemeneij F; Slagboom T; v d Wieken R; Serruys PW; Laarman GJ
    Int J Cardiovasc Intervent; 2003; 5(3):143-50. PubMed ID: 12959731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy after coronary-artery stenting.
    LoGerfo FW
    N Engl J Med; 1999 Apr; 340(17):1365-6; author reply 1367-8. PubMed ID: 10223874
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized trial of stenting with or without balloon predilation for the treatment of coronary artery disease.
    Kovar LI; Monrad ES; Sherman W; Kunchithapatham S; Ravi KL; Gotsis W; Silverman G; Brown DL
    Am Heart J; 2001 Nov; 142(5):E9. PubMed ID: 11685184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery stents. American College of Cardiology.
    Pepine CJ; Holmes DR
    J Am Coll Cardiol; 1996 Sep; 28(3):782-94. PubMed ID: 8772772
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of general usage of stents on short- and long-term health care costs following percutaneous coronary intervention.
    Odell A; Landelius P; Astrom-Olsson K; Grip L
    Cardiology; 2008; 109(2):85-92. PubMed ID: 17664872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative economic analyses of minimally invasive direct coronary artery bypass surgery.
    Gray DT; Veenstra DL
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):618-24. PubMed ID: 12658204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of minimally invasive cardiac operations.
    Ferraris VA; Ferraris SP
    Heart Surg Forum; 2001; 4 Suppl 1():S30-4. PubMed ID: 11178305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What aspects are inefficient concerning percutaneous coronary intervention in Japan?: International cost-effectiveness comparisons].
    Chino M; Sakamoto M; Sasaki T; Isshiki T
    J Cardiol; 2004 Sep; 44(3):85-92. PubMed ID: 15500158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-procedure heparin: boon or burden?
    Kong DF; Califf RM
    Am Heart J; 1998 Aug; 136(2):183-5. PubMed ID: 9704676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.